On Monday, Alpine Immune Sciences Inc (NASDAQ: ALPN) opened higher 0.05% from the last session, before settling in for the closing price of $64.55. Price fluctuations for ALPN have ranged from $6.71 to $64.57 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 171.70% over the past five years. Company’s average yearly earnings per share was noted -174.80% at the time writing. With a float of $47.05 million, this company’s outstanding shares have now reached $60.35 million.
Let’s look at the performance matrix of the company that is accounted for 142 employees.
Alpine Immune Sciences Inc (ALPN) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Alpine Immune Sciences Inc is 28.22%, while institutional ownership is 68.42%. The most recent insider transaction that took place on Jan 26 ’24, was worth 2,745,830. In this transaction an insider of this company sold 117,764 shares at a rate of $23.32, taking the stock ownership to the 0 shares. Before that another transaction happened on Jan 25 ’24, when Company’s insider sold 236 for $22.00, making the entire transaction worth $5,192. This insider now owns 0 shares in total.
Alpine Immune Sciences Inc (ALPN) Performance Highlights and Predictions
If we go through the results of last quarter, which was made public on 12/31/2023, the company posted $0.12 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -$0.34) by $0.46. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.42 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -174.80% per share during the next fiscal year.
Alpine Immune Sciences Inc (NASDAQ: ALPN) Trading Performance Indicators
Check out the current performance indicators for Alpine Immune Sciences Inc (ALPN). In the past quarter, the stock posted a quick ratio of 7.86. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 71.90.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.69, a number that is poised to hit -0.43 in the next quarter and is forecasted to reach -1.96 in one year’s time.
Technical Analysis of Alpine Immune Sciences Inc (ALPN)
Alpine Immune Sciences Inc (NASDAQ: ALPN) saw its 5-day average volume 2.77 million, a positive change from its year-to-date volume of 1.92 million. As of the previous 9 days, the stock’s Stochastic %D was 99.82%. Additionally, its Average True Range was 2.55.
During the past 100 days, Alpine Immune Sciences Inc’s (ALPN) raw stochastic average was set at 100.00%, which indicates a significant increase from 100.00% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 153.15% in the past 14 days, which was higher than the 83.00% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $40.55, while its 200-day Moving Average is $21.24. Nevertheless, the first resistance level for the watch stands at $64.63 in the near term. At $64.67, the stock is likely to face the second major resistance level. The third major resistance level sits at $64.77. If the price goes on to break the first support level at $64.49, it is likely to go to the next support level at $64.39. Assuming the price breaks the second support level, the third support level stands at $64.35.
Alpine Immune Sciences Inc (NASDAQ: ALPN) Key Stats
There are currently 65,546K shares outstanding in the company with a market cap of 4.23 billion. Presently, the company’s annual sales total 58,880 K according to its annual income of -32,180 K. Last quarter, the company’s sales amounted to 30,850 K and its income totaled 5,960 K.
